The Kolkata Pain Crisis Needs Better Diagnostics
Kolkata has one of the highest rates of musculoskeletal disease in India. Humidity, pollution, a genetically higher prevalence of rheumatoid arthritis, and the city's growing sedentary workforce combine to create a population with exceptional levels of chronic joint pain.
Yet most patients in Kolkata are still being diagnosed the same way they were 30 years ago — X-ray, MRI, then 'let's try these painkillers.' The diagnostic gap between what imaging shows and what is actually driving pain is enormous — and it is the reason so many Kolkata patients cycle through years of treatment without lasting relief.
At OPTM's Gariahat clinic, we've deployed AI-driven biomarker testing that changes everything. Instead of just seeing the damage, we identify WHY the damage is happening. Our system analyses inflammatory markers like IL-6, CRP, and TNF-alpha alongside metabolic indicators including MMP-3, vitamin D, and uric acid to build a complete picture of your joint health at the cellular level.
This means we don't just treat symptoms — we address the root cause. And we do it without a single incision, injection, or surgical procedure.
Since opening our Gariahat clinic, over 10,000 patients from across West Bengal, Bangladesh, and eastern India have undergone the AI diagnostic assessment. The most common finding is that their primary treating physician had correctly identified the affected joint — but had incorrectly identified the metabolic driver. This means they were receiving treatment targeting the wrong pathways, which is why the treatment wasn't working.
We can correct that. And the assessment takes one visit, one blood draw, and 48 hours for results.
Related Clinical Resources
